Growth Metrics

Pfizer (PFE) Total Debt (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -0.52%
Dec 31, 2025 5.00%
Sep 28, 2025 -0.14%
Jun 29, 2025 -0.50%
Mar 30, 2025 -2.87%
Dec 31, 2024 -5.55%
Sep 29, 2024 -2.52%
Jun 30, 2024 -0.13%
Mar 31, 2024 -3.27%
Dec 31, 2023 13.04%
Oct 1, 2023 -2.67%
Jul 2, 2023 82.05%
Apr 2, 2023 0.18%
Dec 31, 2022 -2.29%
Oct 2, 2022 -8.97%
Jul 3, 2022 10.97%
Apr 3, 2022 -5.07%
Dec 31, 2021 -4.11%
Oct 3, 2021 1.62%
Jul 4, 2021 -1.15%
Apr 4, 2021 -0.34%
Dec 31, 2020 -36.92%
Sep 27, 2020 -0.73%
Jun 28, 2020 21.66%
Mar 29, 2020 0.26%
Dec 31, 2019 -0.97%
Sep 29, 2019 12.82%
Jun 30, 2019 3.39%
Mar 31, 2019 8.15%
Dec 31, 2018 1.71%
Sep 30, 2018 1.28%
Jul 1, 2018 -0.79%
Apr 1, 2018 -6.09%
Dec 31, 2017 -1.05%
Oct 1, 2017 0.56%
Jul 2, 2017 -0.69%
Apr 2, 2017 4.57%
Dec 31, 2016 -4.50%
Oct 2, 2016 -0.25%
Jul 3, 2016 12.22%
Apr 3, 2016 1.21%
Dec 31, 2015 0.01%
Sep 27, 2015 10.75%
Jun 28, 2015 -2.23%
Mar 29, 2015 -2.06%
Dec 31, 2014 -1.01%
Sep 28, 2014 -2.04%
Jun 29, 2014 2.33%
Mar 30, 2014 1.31%
Dec 31, 2013 -0.17%
Sep 29, 2013 -0.53%
Jun 30, 2013 -8.99%
Mar 31, 2013 7.79%
Dec 31, 2012 -3.60%
Sep 30, 2012 0.74%
Jul 1, 2012 -1.27%
Apr 1, 2012 0.33%
Dec 31, 2011 -5.10%
Oct 2, 2011 -1.62%
Jul 3, 2011 0.75%
Apr 3, 2011 -5.93%
Dec 31, 2010 -0.35%
Oct 3, 2010 2.07%
Jul 4, 2010 -6.03%
Apr 4, 2010 6.55%
Dec 31, 2009 9.82%
Sep 27, 2009 -0.39%